
IPOCLYD
Clywedog Therapeutics Holdings IPO Preview: Diabetes Bet Meets Execution Risk
Clywedog Therapeutics Holdings, Inc. Common Stock (NASDAQ: CLYD) is expected to list on 2026-11-23, but the price range has not been disclosed. The company is coming public through a merger-driven listing path rather than a traditional standalone IPO. Bull case: an oral diabetes program with early human data; bear case: no revenue, limited cash, and a going-concern warning.
Nov 21, 20265 MIN